Prognostic Impact of Nutritional Status on Overall Survival and Health-Related Quality of Life in Men with Advanced Prostate Cancer

被引:3
作者
Cavka, Luka [1 ,2 ]
Perme, Maja Pohar [3 ]
Kozjek, Nada Rotovnik [4 ]
Seruga, Bostjan [1 ]
机构
[1] Univ Ljubljana, Fac Med, Inst Oncol Ljubljana, Div Med Oncol, Zaloska Cesta 2, Ljubljana 1000, Slovenia
[2] Univ Med Ctr Maribor, Dept Oncol, Ljubljanska Ul 5, Maribor 2000, Slovenia
[3] Univ Ljubljana, Fac Med, Inst Biostat & Med Informat, Vrazov Trg 2, Ljubljana 1000, Slovenia
[4] Inst Oncol Ljubljana, Dept Clin Nutr, Zaloska Ul 2, Ljubljana 1000, Slovenia
关键词
nutritional risk; malnutrition; metastatic castrate-resistant prostate cancer; outcomes; CACHEXIA; MALNUTRITION; OUTCOMES; WEIGHT; PREVALENCE; SARCOPENIA;
D O I
10.3390/nu15041044
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Purpose: Prognostic role of nutritional status (NS) in patients with metastatic castrate-resistant prostate cancer (mCRPC) is unknown. We hypothesized that patients' NS at the presentation of mCRPC is prognostic for health-related quality of life (HRQoL) and overall survival (OS). Methods: We conducted a prospective observational study in mCRPC patients. At enrollment, we allocated each patient into one of four NS categories: (i) well-nourished (WN), (ii) nutritional risk without sarcopenia/cachexia (NR), (iii) sarcopenia, or (iv) cachexia. We sought the prognostic role of the NS for OS and HRQoL by regression models. Results: 141 patients were included into our study. When compared to WN patients, those with NR and cachexia had a higher chance of worse HRQoL (OR 3.45; 95% CI [1.28 to 9.09], and OR 4.17; 95% CI [1.28 to 12.5], respectively), as well as shorter OS (HR 2.04; 95% CI [1.19 to 3.39] and HR 2.9; 95% CI [1.56 to 5.41], respectively). However, when accounting for possible confounding factors, we could not prove the significant importance of NS for chosen outcomes. Conclusions: Suboptimal NS might be an unfavorable prognostic factor for HRQoL and OS. Further interventional studies focusing on therapy or prevention are warranted.
引用
收藏
页数:12
相关论文
共 37 条
[1]   Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: A population-based study [J].
Arndt, V ;
Merx, H ;
Stegmaier, C ;
Ziegler, H ;
Brenner, H .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) :4829-4836
[2]   Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy [J].
Baracos, V. E. ;
Arribas, L. .
ANNALS OF ONCOLOGY, 2018, 29 :1-9
[3]   Health-related quality of life among prostate cancer patients: real-life situation at the beginning of treatment [J].
Bergius, Susanne ;
Torvinen, Saku ;
Muhonen, Timo ;
Roine, Risto P. ;
Sintonen, Harri ;
Taari, Kimmo .
SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 (01) :13-19
[4]   Cancer Cachexia: Beyond Weight Loss [J].
Bruggeman, Andrew R. ;
Kamal, Arif H. ;
LeBlanc, Thomas W. ;
Ma, Joseph D. ;
Baracos, Vickie E. ;
Roeland, Eric J. .
JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (11) :1163-+
[5]   Exercise Recommendation for People With Bone Metastases: Expert Consensus for Health Care Providers and Exercise Professionals [J].
Campbell, Kristin L. ;
Cormie, Prue ;
Weller, Sarah ;
Alibhai, Shabbir M. H. ;
Bolam, Kate A. ;
Campbell, Anna ;
Cheville, Andrea L. ;
Dalzell, Mary-Ann ;
Hart, Nicolas H. ;
Higano, Celestia S. ;
Lane, Kirstin ;
Mansfield, Sami ;
McNeely, Margaret L. ;
Newton, Robert U. ;
Quist, Morten ;
Rauw, Jennifer ;
Rosenberger, Friederike ;
Santa Mina, Daniel ;
Schmitz, Kathryn H. ;
Winters-Stone, Kerri M. ;
Wiskemann, Joachim ;
Goulart, Jennifer .
JCO ONCOLOGY PRACTICE, 2022, 18 (05) :361-E709
[6]   Prognostic role of nutritional status (NS) for health-related quality of life (HRQoL) in men with advanced prostate cancer [J].
Cavka, L. ;
Perme, M. Pohar ;
Zakotnik, B. ;
Kozjek, N. Rotovnik ;
Seruga, B. .
ANNALS OF ONCOLOGY, 2020, 31 :S540-S540
[7]   Nutritional Status and Health-Related Quality of Life in Men with Advanced Castrate-Resistant Prostate Cancer [J].
Cavka, Luka ;
Perme, Maja Pohar ;
Zakotnik, Branko ;
Kozjek, Nada Rotovnik ;
Seruga, Bostjan .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (02) :472-481
[8]   ESPEN guidelines on definitions and terminology of clinical nutrition [J].
Cederholm, T. ;
Barazzoni, R. ;
Austin, P. ;
Ballmer, P. ;
Biolo, G. ;
Bischoff, S. C. ;
Compher, C. ;
Correia, I. ;
Higashiguchi, T. ;
Hoist, M. ;
Jensen, G. L. ;
Malone, A. ;
Muscaritoli, M. ;
Nyulasi, I. ;
Pirlich, M. ;
Rothenberg, E. ;
Schindler, K. ;
Schneider, S. M. ;
de van der Schueren, M. A. E. ;
Sieber, C. ;
Valentini, L. i ;
Yu, J. C. ;
Van Gossum, A. ;
Singer, P. .
CLINICAL NUTRITION, 2017, 36 (01) :49-64
[9]   Role of quality of life in men with metastatic hormone-refractory prostate cancer: How does atrasentan influence quality of life? [J].
Cella, D ;
Petrylak, DP ;
Fishman, M ;
Teigland, C ;
Young, J ;
Mulani, P .
EUROPEAN UROLOGY, 2006, 49 (05) :781-789
[10]   The Diversity of Nutritional Status in Cancer: New Insights [J].
Chaves, Mariana Ramos ;
Boleo-Tome, Carolina ;
Monteiro-Grillo, Isabel ;
Camilo, Maria ;
Ravasco, Paula .
ONCOLOGIST, 2010, 15 (05) :523-530